Submit your email to push it up the queue
Abbott Laboratories (Pakistan) Limited, a subsidiary of the global healthcare giant Abbott Laboratories, is headquartered in Karachi, Pakistan. Established in 1948, the company has significantly contributed to the pharmaceutical and healthcare sectors in the region, focusing on nutrition, diagnostics, and pharmaceuticals. With a diverse portfolio that includes innovative products such as infant formula, nutritional supplements, and advanced diagnostic tools, Abbott Laboratories (Pakistan) Limited stands out for its commitment to quality and research-driven solutions. The company has achieved notable milestones, including the introduction of cutting-edge medical technologies that enhance patient care. As a leader in the healthcare industry, Abbott Laboratories (Pakistan) Limited continues to strengthen its market position through a dedication to improving health outcomes and expanding access to essential healthcare products across the country.
How does Abbott Laboratories (Pakistan) Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Abbott Laboratories (Pakistan) Limited's score of 56 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Abbott Laboratories (Pakistan) Limited currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Abbott Laboratories, and any climate commitments or emissions data would be cascaded from its parent organisation. As part of its corporate family, Abbott Laboratories (Pakistan) Limited adheres to the sustainability initiatives and targets set by Abbott Laboratories, which operates at a higher cascade level. However, specific reduction targets or achievements for Abbott Laboratories (Pakistan) Limited are not detailed in the available information. The company is involved in broader climate initiatives, including participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are managed at the parent company level. These initiatives aim to align corporate emissions reductions with climate science and promote transparency in environmental impact. In summary, while Abbott Laboratories (Pakistan) Limited does not provide specific emissions data or reduction targets, it is part of a larger corporate structure that is committed to sustainability and climate action through its parent company, Abbott Laboratories.
Access structured emissions data, company-specific emission factors, and source documents
2010 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | 578,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 691,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | - | - | - | - | - | - | - | - | - | - | - | 00,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Abbott Laboratories (Pakistan) Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.